TS
CERE

Twin Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Twin Securities’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-416,657
Closed -$17M – 20
2024
Q2 		$17M Buy
416,657
+315,381
+311% +$13.1M 13.4% 3
2024
Q1 		$4.28M Sell
101,276
-131,429
-56% -$5.52M 4.27% 6
2023
Q4 		$9.87M Buy
+232,705
New +$6.69M 10.41% 3

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Twin Securities's CERE Position: Q3 2024 in Review

Twin Securities sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 416,657 shares — an estimated $17M sold.

Twin Securities first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $17M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Twin Securities reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Twin Securities sold 416,657 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $17M.
  • Twin Securities first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Twin Securities's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $17M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Twin Securities's 13F filing for Q3 2024, filed 14 Nov 2024.